Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
An average weight loss of 10 to 15% can effectively reduce obesity-related complications like hypertension, sleep apnea, and type 2 diabetes
TRANSCEND-T2D-1: Retatrutide Phase 3 Diabetes Results (March 2026) First Phase 3 retatrutide trial in type 2 diabetes 16.8% weight loss and -2.0% A1C at 12 mg over 40 weeks
Pick a convenient day and time, and our medical experts will contact you for a quick wellness review
*In-competition refers to the period commencing at 11:59 pm on the day before a competition in which the athlete is scheduled to compete through the end of such competition and the sample collection process related to such competition
It appears to selectively stimulate GH release without affecting cortisol, prolactin, or aldosterone
US$ 23.25
US$ 25.02
US$ 21.94
US$ 21.65
